The novel HSP90 inhibitor STA-9090 exhibits activity against Kit-dependent and -independent malignant mast cell tumors

Tzu‐yin Lin(The Ohio State University), Misty D. Bear(The Ohio State University), Zhenjian Du(Synta Pharmaceuticals (United States)), Kevin P. Foley(Synta Pharmaceuticals (United States)), Weiwen Ying(Synta Pharmaceuticals (United States)), James Barsoum(Synta Pharmaceuticals (United States)), Cheryl A. London(The Ohio State University)
Experimental Hematology
July 27, 2008
10.1016/j.exphem.2008.05.001
Cited by 109

Abstract

Related Papers

No related papers found

Powered by citation graph analysis